Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:06:37.482Z.
Calculation as of: 2026-10-06T17:06:37.482Z.
Quote observation: 2026-10-06T17:05:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f06204e81c8a2ed41a5798160e844c591f5150b644efe168084329023db9ebc4
EARNINGS YIELD
N/A
DiaMedica Therapeutics Inc.
Market Cap
$448.58M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$446.63M
Earnings Yield
N/A
TTM Avg
49.38%
3Y Avg
49.38%
5Y Avg
49.38%
Market Cap
$440.82M
Earnings Yield
N/A
TTM Avg
1.29%
3Y Avg
1.29%
5Y Avg
1.29%
Market Cap
$435.58M
Earnings Yield
2.50%
TTM Avg
1.91%
3Y Avg
1.91%
5Y Avg
1.91%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | $448.58M | N/A | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $446.63M | N/A | 49.38% | 49.38% | 49.38% |
| NeuroPace, Inc. (NPCE)vs › | $444.41M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $440.82M | N/A | 1.29% | 1.29% | 1.29% |
| NRC Health (NRC)vs › | $459.97M | 1.24% | 3.15% | 4.59% | 4.10% |
| Assembly Biosciences, Inc. (ASMB)vs › | $435.58M | 2.50% | 1.91% | 1.91% | 1.91% |
| Editas Medicine, Inc. (EDIT)vs › | $433.53M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $433.73M | N/A | 4.67% | 2.17% | 1.96% |
| Sight Sciences, Inc. (SGHT)vs › | $468.08M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $471.02M | N/A | 6.10% | 6.10% | 6.10% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
